High Point Advisor Group LLC Collegium Pharmaceutical, Inc Transaction History
High Point Advisor Group LLC
- $1.7 Billion
- Q1 2025
A detailed history of High Point Advisor Group LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, High Point Advisor Group LLC holds 7,790 shares of COLL stock, worth $229,805. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,790
Previous 9,440
17.48%
Holding current value
$229,805
Previous $270,000
14.07%
% of portfolio
0.01%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding COLL
# of Institutions
254Shares Held
37.2MCall Options Held
61.1KPut Options Held
5.8K-
Black Rock Inc. New York, NY5.79MShares$171 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3MShares$88.5 Million2.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$77.9 Million1.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$66.3 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.63MShares$48.2 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.01B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...